BridgeBio Pharma, Inc. Amortization of Debt Issuance Costs
BridgeBio Pharma, Inc. (BBIO) reported Amortization of Debt Issuance Costs of $23.00 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2021-11-04
- BridgeBio Pharma, Inc. amortization of debt issuance costs for the quarter ending 2021-09-30 was $23.00K.
- BridgeBio Pharma, Inc. amortization of debt issuance costs for the quarter ending 2021-06-30 was $24.00K.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 4 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 7 month | Amortization of Debt Issuance Costs 9 month |
|---|---|---|---|---|---|
| 2021-09-30 | $23.00K 10-Q · filed 2021-11-04 | $47.00K derived: sum of 2 quarters · filed 2021-11-04 | $70.00K 10-Q · filed 2021-11-04 | ||
| 2021-06-30 | $24.00K 10-Q · filed 2021-08-05 | $47.00K 10-Q · filed 2021-08-05 | |||
| 2020-09-30 | $528.00K 10-Q · filed 2021-11-04 | ||||
| 2020-06-30 | $289.00K 10-Q · filed 2021-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |